Aerosolized Agents - metered-dose inhalers: beta2 adrenergic drugs (long-acting)

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

  • Revision history
    • Revised April 23, 2021; March 2019; March 2017; Oct. 2014; Feb. 2013; Oct. 2012; Jan. 2011; July 2007; March 2003; April 2002; March 2001; March 2000; Feb. 1999; March 1998; March 1997; Aug. 1995.
  • Initially developed
    • Jan. 1995